Ubs Group Ag Heart Test Laboratories, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.78 - $3.4 $658 - $2,869	-844 Reduced 43.22%	1,109 $1,000
Q4 2022 Feb 08, 2023	BUY	$0.8 - $267.0 $115 - $38,448	144 Added 7.96%	1,953 $1,000
Q3 2022 Nov 10, 2022	SELL	$1.15 - $126.0 $2,869 - $314,370	-2,495 Reduced 57.97%	1,809 $2,000
Q2 2022 Aug 10, 2022	BUY	$1.78 - $170.0 $7,661 - $731,680	4,304 New	4,304 $8,000

Ticker HSCS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,202,550
Market Cap $23.8M
Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.